Healthcare systems around the world continue to struggle with the growing impact of complex chronic diseases, which affect billions of people and account for more than 80 percent of global healthcare spending.
In a new article for Healthcare Leader, PrecisionLife CEO Steve Gardner explains how our next generation precision medicine tools based on mechanism level insights can transform care by improving diagnosis, reducing clinical waste and helping clinicians match patients to treatments that work for them.
The piece highlights how these approaches are already being deployed with leading healthcare partners and outlines the opportunity to deliver better outcomes across autoimmune, neurological, metabolic and women’s health conditions.
Read the full article in Healthcare Leader.
